- Home
- OKYO vs RMI Comparison
OKYO vs RMI Comparison
Compare OKYO & RMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OKYO
- RMI
- Stock Information
- Founded
- OKYO 2007
- RMI 2018
- Country
- OKYO United Kingdom
- RMI United States
- Employees
- OKYO N/A
- RMI N/A
- Industry
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- RMI Finance/Investors Services
- Sector
- OKYO Health Care
- RMI Finance
- Exchange
- OKYO Nasdaq
- RMI Nasdaq
- Market Cap
- OKYO 79.7M
- RMI 94.0M
- IPO Year
- OKYO 2022
- RMI N/A
- Fundamental
- Price
- OKYO $1.99
- RMI $14.56
- Analyst Decision
- OKYO Strong Buy
- RMI
- Analyst Count
- OKYO 1
- RMI 0
- Target Price
- OKYO $7.00
- RMI N/A
- AVG Volume (30 Days)
- OKYO 118.6K
- RMI 17.4K
- Earning Date
- OKYO 07-18-2025
- RMI 01-01-0001
- Dividend Yield
- OKYO N/A
- RMI 7.28%
- EPS Growth
- OKYO N/A
- RMI N/A
- EPS
- OKYO N/A
- RMI N/A
- Revenue
- OKYO N/A
- RMI N/A
- Revenue This Year
- OKYO N/A
- RMI N/A
- Revenue Next Year
- OKYO N/A
- RMI N/A
- P/E Ratio
- OKYO N/A
- RMI N/A
- Revenue Growth
- OKYO N/A
- RMI N/A
- 52 Week Low
- OKYO $0.90
- RMI $13.05
- 52 Week High
- OKYO $3.35
- RMI $17.37
- Technical
- Relative Strength Index (RSI)
- OKYO 39.72
- RMI 56.17
- Support Level
- OKYO $1.90
- RMI $14.31
- Resistance Level
- OKYO $2.54
- RMI $14.65
- Average True Range (ATR)
- OKYO 0.25
- RMI 0.19
- MACD
- OKYO -0.06
- RMI -0.01
- Stochastic Oscillator
- OKYO 6.83
- RMI 75.75
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
About RMI RiverNorth Opportunistic Municipal Income Fund Inc.
RiverNorth Opportunistic Municipal Income Fund, Inc. is a diversified, closed-end management investment company. Its investment objective is to seek current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.